At the 6th Annual National Conference to Defeat Cancer, organized by Coalition Priorité Cancer, Merck Canada reinforced the company’s continued commitment to the Quebec life sciences research innovation sector by announcing a $2-million grant to the Quebec – Consortium de recherche en oncologie clinique (Q-CROC).
Merck Canada announces $2-million grant to support personalized treatment in cancer
Apr 3, 2014 | News